{"id":703038,"date":"2024-06-18T10:22:01","date_gmt":"2024-06-18T10:22:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=703038"},"modified":"2024-06-18T10:22:01","modified_gmt":"2024-06-18T10:22:01","slug":"ibogaine-by-david-dardashti-revolutionizes-ibogaine-software-with-partial-fraction-decomposition","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/ibogaine-by-david-dardashti-revolutionizes-ibogaine-software-with-partial-fraction-decomposition_703038.html","title":{"rendered":"Ibogaine By David Dardashti Revolutionizes Ibogaine Software with Partial Fraction Decomposition"},"content":{"rendered":"
Ibogaine By David Dardashti, a pioneering provider of ibogaine treatment and research, today announced the integration of partial fraction decomposition into its proprietary software platform. This cutting-edge feature enables the company to more accurately measure the absorption rate of ibogaine booster treatments, paving the way for personalized and optimized treatment plans.<\/div>\n

Inspired by integral calculus models used to determine dosages based on individual patient factors like age, weight, and height, Ibogaine By David Dardashti’s partial fraction decomposition method provides a deeper understanding of how ibogaine is absorbed and processed in the body. By analyzing the distinct components of the absorption process, the company’s team of experts can fine-tune booster dosages to maximize therapeutic outcomes while minimizing potential side effects.<\/p>\n

“We are incredibly excited to introduce this breakthrough technology to our patients,” said David Dardashti, founder and CEO of Ibogaine By David Dardashti. “Partial fraction decomposition represents a major leap forward in the field of ibogaine therapy, allowing us to deliver more targeted and effective treatments. This innovation is a testament to our unwavering commitment to scientific rigor and our passion for helping individuals overcome addiction.”<\/p>\n

Ibogaine By David Dardashti’s partial fraction decomposition feature is now available to all current and future patients.For more information or to schedule a consultation, please visit www.ibogaineclinic.com<\/p>\n

About Ibogaine By David Dardashti<\/strong><\/p>\n

Ibogaine By David Dardashti is a leading provider of ibogaine treatment and research, dedicated to helping individuals overcome addiction through safe, effective, and personalized care. With a team of experienced professionals and a commitment to scientific excellence, the company is at the forefront of ibogaine therapy innovation.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Ibogaine By David Dardashti<\/a>
Contact Person:<\/strong> Cole Barressi
Email:<\/strong> Send Email<\/a>
Country:<\/strong> United States
Website:<\/strong> www.ibogaineclinic.com<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Ibogaine By David Dardashti, a pioneering provider of ibogaine treatment and research, today announced the integration of partial fraction decomposition into its proprietary software platform. This cutting-edge feature enables the company to more accurately measure the absorption rate of ibogaine … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[421,408,405,420,411],"tags":[],"class_list":["post-703038","post","type-post","status-publish","format-standard","hentry","category-Computers-Software","category-Electronics-Semiconductors","category-Health-Medicine","category-Science","category-Technology"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/703038","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=703038"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/703038\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=703038"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=703038"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=703038"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}